You are here

Vaccines Pipeline

Pfizer's mission is to deliver medicines that make a real difference in quality of life for patients with vaccines-related conditions. Scientists in our research and development (R&D) programs are committed to speeding the delivery of new treatments. We pledge to maintain the safety of patients who take part in our trials and to uphold the highest ethical standards in all of our research initiatives.

On this page, you will find more information about our pipeline, which investigational therapies are under development, and in which stages.

 

Vaccines as of May 2, 2017

  • Discovery Projects
  • Phase 1
    2
  • Phase 2
    1
  • Phase 3
    1
  • Registration
    1
  • Total5
 
Compound Name
Indication
Phase
Submission Type
Compound Type
4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) (PF-06290510)
Therapeutic Area:
Vaccines
Phase:Phase 2
Compound Type:Vaccine
Business Segment:
Pfizer Innovative Health
Mechanism of Action:
Prophylactic Vaccine
Go to clinical trial
Staph aureus (FAST TRACK) Phase 2 New Molecular Entity Vaccine
PF-06425090
Therapeutic Area:
Vaccines
Phase:Phase 3
Compound Type:Vaccine
Business Segment:
WRD
Mechanism of Action:
Prophylactic Vaccine
Go to clinical trial
Clostridium difficile Colitis (FAST TRACK) Phase 3 New Molecular Entity Vaccine
PF-06482077
Therapeutic Area:
Vaccines
Phase:Phase 1
Compound Type:Vaccine
Business Segment:
WRD
Mechanism of Action:
Pneumococcal Vaccine
Go to clinical trial
Bacterial Infections Phase 1 New Molecular Entity Vaccine
PF-06753512
Therapeutic Area:
Vaccines
Phase:Phase 1
Compound Type:Vaccine
Business Segment:
WRD
Mechanism of Action:
Therapeutic Vaccine
Go to clinical trial
Prostate Cancer Phase 1 New Molecular Entity Vaccine
Trumenba (MnB rLP2086)
Therapeutic Area:
Vaccines
Phase:Registration
Compound Type:Vaccine
Business Segment:
Pfizer Innovative Health
Mechanism of Action:
Prophylactic Vaccine
Go to clinical trial
Adolescent and Young Adult Meningitis B (E.U.) Registration New Molecular Entity Vaccine